In some studies, selected study sites will recruit patients from a large geographical area and provide the experimental treatment. It may be relevant to transfer some tasks to local hospitals without them being set up as separate sites. This transfer must be described in the protocol. Information can be found in SOP Overføring av enkelte behandlinger mellom sykehus (Norwegian). Risk assessments throughout the lifespan of the study are mandatory, see SOP Quality and Risk Management and template Risikovurdering (Norwegian).